Drug Development and Strategy - Connected Health Pulse

Outsourcing In Drug Development: A Key Strategy for Sustainable Growth

Electronic Health Reporter

NOVEMBER 18, 2024

One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development. As companies […] The article Outsourcing In Drug Development: A Key Strategy for Sustainable Growth appeared first on electronichealthreporter.com.

Drug Development

Drug Development Pharmaceuticals

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

JANUARY 23, 2024

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D.,

Drug Development

Drug Development Pharmaceuticals Life Science BioTech

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development. For more information on SSI Strategy, please visit www.ssistrategy.com.

Life Science

Life Science Drug Development BioTech Leadership

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care.

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health

Health Consumers Are Now Amazon-Primed for Healthcare – HealthConsuming Explains, Part 2

Health Populi

APRIL 29, 2019

The bar chart from research by Market Strategies shows that a plurality of consumers also trusts Amazon to try on for healthcare products and services. The Amazon Prime-ing of the U.S. ” People trust Amazon for daily retail experiences. The company has been multi-tasking a broad range of tactics throughout the health care ecosystem.

HIPAA

HIPAA Drug Development Digital Health Mental health

Cost of antibiotic-resistant infections in U.S. tops $2B per year

FierceHealthIT

MARCH 22, 2018

The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development. Multiply that by the estimated number of antibiotic-resistant infections, and costs run well over $2 billion per year.

Drug Development

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech

BioTech Drug Development Meaningful Use Pharmaceuticals

Vital Lines September 2023

Redox

SEPTEMBER 26, 2023

Don’t get so immersed in system processing that you overlook data quality and accessibility, says Deloitte’s Cloud Strategy Officer. Read more Patient engagement Pharma falls short of patient-centricity Experts say orphan drug developers need tech infrastructure, policies, and procedures to overcome patients’ distrust.

FHIR

FHIR Drug Development Telehealth Digital Health

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development

Drug Development Digital Health

Digital Health Technologies in Clinical Trials

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.

Health Technology

Health Technology Digital Health Life Science BioTech

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

JANUARY 8, 2024

Now, they have new tools such as artificial intelligence (AI) and machine learning (ML) that they can leverage to automatically scour medical literature for information to assist signal evaluation and medical review, or real-world-evidence insights that can lead to drug-safety improvements. Dave Latshaw, CEO at BioPhy 1.

Health IT

Health IT Drug Development Pharmaceuticals BioTech

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

JUNE 17, 2023

As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. This could lead to mergers between companies that specialize in different aspects of personalized medicine, such as data analytics, genomics, and drug development.

Digital Health

Digital Health Drug Development Telemedicine Telehealth

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

NOVEMBER 16, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Drug Development

Drug Development healthcare technology Leadership Life Science

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

JUNE 13, 2023

We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re

Drug Development

Drug Development eMed BioTech Digital Health

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

APRIL 25, 2024

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Koneksa aims to revolutionize treatment effect detection in clinical research and improve patient outcomes.

Health Data

Health Data BioTech Drug Development healthcare technology

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

Healthcare IT Today

NOVEMBER 1, 2022

The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.

Life Science

Life Science Drug Development Digital Health Health IT

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Don’t wait until you have a “fully-baked” digital health strategy to begin weighing the pros and cons of DTx implementation.

Digital Health

Digital Health Drug Development Pharmaceuticals Nursing

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech

BioTech Drug Development Life Science Pharmaceuticals

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science

Life Science Drug Development BioTech Pharmaceuticals

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

OCTOBER 14, 2024

Investment Strategy: The investment landscape for healthcare startups and emerging technologies. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Health Policy: The impact of healthcare policy on patient outcomes and access to care.

Leadership

Leadership healthcare technology Digital Health Mental health

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

DECEMBER 2, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Mental health

Mental health Digital Health healthcare technology Telehealth

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development

Drug Development Health science healthcare technology Leadership

Clinical Value of Digital Phenotyping in Mental Health

Lloyd Price

AUGUST 3, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Mental health

Mental health Pain management Drug Development Leadership

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Interoperability

Interoperability healthcare technology HIPAA Leadership

Catawba Research Expands Scientific Advisory Board With Renowned Experts in Immunology and Dermatology

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. Cees Wortel, Ph.D., After earning his M.D.

Leadership

Leadership Pharmaceuticals Drug Development Digital Health

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.”

Life Science

Life Science Digital Health Drug Development Patient Experience

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

healthcare technology

healthcare technology Drug Development Leadership Digital Health

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

Lloyd Price

MAY 30, 2024

As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to develop strategy and implementation, effectively communicate the benefits and risks of AI to all stakeholders and oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulation.

Leadership

Leadership healthcare technology Interoperability Drug Development

Prognos Health Raises $23 Million

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science

Life Science Drug Development Health IT Healthcare IT

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

Lloyd Price

SEPTEMBER 16, 2024

Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!

Digital Health

Digital Health Drug Development healthcare technology Leadership

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. By using this technology in innovative ways, healthcare organisations can improve patient care, reduce costs, and accelerate the development of new treatments. Visit www.nelsonadvisors.co.uk Subscribe Today!

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data

Digital Health Global

MAY 29, 2024

“Masimo’s SET ® pulse oximetry is sensitive enough to capture key vitals on the very ill like cancer patients, plus it works on all skin tones, all ages, and is easy to use,” said Musaddiq Khan, Medable’s Vice President of Digital Outcomes and TA Strategy. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Drug Development

Drug Development Digital Health

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Digital Health Global

JANUARY 4, 2024

Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster. Koneksa aims to revolutionize treatment effect detection in clinical research and improve patient outcomes.

Health Technology

Health Technology Digital Health Drug Development healthcare technology

Like banks, healthcare will become digital-first in 2022, Zoom healthcare lead says

Healthcare IT News - Telehealth

JANUARY 20, 2022

As work-from-home technology continues to improve, we expect a positive impact on the research and development side for life sciences organizations. Decentralization in life sciences works across all aspects of the drug development life cycle from R&D, regulatory, clinical drug trials, to manufacturing and GTM strategies.

Life Science

Life Science Primary Care Mental health Drug Development

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe

Digital Health Global

JUNE 2, 2024

” Mark Slaughter , Chief Strategy & Growth Officer at Mika Health, added, “As cancer treatments become more sophisticated and personalized, patients are increasingly unable to identify and access the targeted therapy and psycho-oncological support they need.

Drug Development

Drug Development Pharmaceuticals Mental health Patient Experience

FDA Rejects SGLT Drug Zynquista for T1D Use

Insulin Nation

MARCH 24, 2019

The FDA declined to approve Zynquista a drug developed by Sanofi SA and Lexicon Pharmaceuticals intended for use with insulin in patients with Type 1 Diabetes. The generic name of the drug is sotagliflozin. See this article for details on SGLT2 Inhibitors.

Drug Development

Drug Development Pharmaceuticals

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Healthcare IT Today

DECEMBER 6, 2024

In total, Aignostics has now raised over $55 million , reflecting investors’ confidence in its differentiated AI models and clear commercial strategy. “At its core, Aignostics is a world-class machine learning company,” said Julian Zachmann at ATHOS.

Life Science

Life Science Drug Development Health IT Healthcare IT

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

DECEMBER 2, 2024

The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!

Digital Health

Digital Health healthcare technology Telemedicine Leadership

Neuralink, Brain Computer Interfaces and Neuroscience innovation primed for mainstream growth in 2025

Lloyd Price

OCTOBER 9, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Mental health

Mental health healthcare technology Leadership Digital Health

What can Healthcare AI learn from Weather AI?

Lloyd Price

MAY 6, 2024

Healthcare AI can adopt similar strategies to integrate and analyse diverse patient data, including medical records, environmental factors, genetic data, and sensor data from wearables. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology

healthcare technology Leadership Drug Development Digital Health

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data

Health Data healthcare technology Digital Health Leadership

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Lloyd Price

AUGUST 7, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Interoperability

Interoperability Leadership EHR Drug Development

Bonus Features – June 26, 2022 – Walgreens gets into clinical trials, ONC offering SDOH grants, and more

Healthcare IT Today

JUNE 26, 2022

The Office of the National Coordinator for Health IT has some money for you. The latest Leading Edge Acceleration Projects (LEAP) in Health IT funding opportunity will award grants to applicants working in two areas.

Drug Development

Drug Development Healthcare IT Health IT Nursing

Asaya and medical cannabis care in the era of personalised medicine

Lloyd Price

MAY 18, 2021

Clearly, personalised medicine is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches.

Drug Development

Drug Development Pharmaceuticals Psychiatry Telemedicine

Outsourcing In Drug Development: A Key Strategy for Sustainable Growth

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Trending Sources

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

The next revolution in the pharmaceutical industry: the transformative potential of AI

Health Consumers Are Now Amazon-Primed for Healthcare – HealthConsuming Explains, Part 2

Cost of antibiotic-resistant infections in U.S. tops $2B per year

Patients and Industry: Starting Our New Life Together in 2023

Vital Lines September 2023

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Digital Health Technologies in Clinical Trials

Pharma IT and AI – 2024 Health IT Predictions

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

HLTH 2024: What are the key talking points likely to be?

Future HealthTech Valuations in 2025: A Dynamic Landscape

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Clinical Value of Digital Phenotyping in Mental Health

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Catawba Research Expands Scientific Advisory Board With Renowned Experts in Immunology and Dermatology

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

Prognos Health Raises $23 Million

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Like banks, healthcare will become digital-first in 2022, Zoom healthcare lead says

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe

FDA Rejects SGLT Drug Zynquista for T1D Use

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Wound Care: Emerging HealthTech market to watch in 2025

Neuralink, Brain Computer Interfaces and Neuroscience innovation primed for mainstream growth in 2025

What can Healthcare AI learn from Weather AI?

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Bonus Features – June 26, 2022 – Walgreens gets into clinical trials, ONC offering SDOH grants, and more

Asaya and medical cannabis care in the era of personalised medicine

Stay Connected